Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The per capita consumption in France of anxiolytic, hypnotic, antidepressant, and neuroleptic drugs is about three times greater than in Germany or Britain: 11% of adults in France take psychotropic drugs at least once a week and for at least six months. A national survey has shown that one in seven prescriptions include at least one psychotropic drug and that 83% of such prescriptions are made out by general practitioners.
Professor Zarifian says that the pharmaceutical industry dominates continued medical education by sponsoring publications and meetings and influencing the editorial content of medical publications. "There is a clear intent to give doctors a monolithic representation [of mental health] reduced only to symptoms and accessible only to drugs," he says in his report. "The manner in which the link between suicide and depression is presented is an example of disinformation with the final objective of having more antidepressants prescribed."
Professor Zarifian said that sales of these drugs increased by 7% from 1993 to 1994. He recognises that unemployment and increasing social breakdown contribute to mental problems. But he fears that the boundary between normal and abnormal is becoming blurred, leading to a "pharmacological medicalisation of existence."
The report recommends a review of the packaging of psychotropic drugs and continued education of doctors on the effects of psychotropic drugs and the handling of mental problems. It also recommends giving as much independence as possible to the medical press and establishing a surveillance network for the prescription and use of psychotropic drugs.
After receiving the report, Herve Gaymard, secretary of state for health, acknowledged that excessive use of psychotropic drugs in France was "a societal phenomenon that concerns all of us." Mr Gaymard announced plans for an evaluation and study of medicinal prescriptions, notably of psychotropic drugs.--ALEXANDER DOROZYNSKI, medical journalist, Paris